Clarius Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $289K | Sell |
3,011
-2,928
| -49% | -$284K | 0.02% | 299 |
|
|
2025
Q3 | $566K | Sell |
5,939
-903
| -13% | -$83K | 0.03% | 192 |
|
|
2025
Q2 | $596K | Buy |
6,842
+2,714
| +66% | +$230K | 0.03% | 217 |
|
|
2025
Q1 | $371K | Buy |
4,128
+285
| +7% | +$25.5K | 0.02% | 298 |
|
|
2024
Q4 | $307K | Sell |
3,843
-5
| -0.1% | -$433 | 0.02% | 313 |
|
|
2024
Q3 | $344K | Sell |
3,848
-289
| -7% | -$24.3K | 0.02% | 289 |
|
|
2024
Q2 | $326K | Buy |
4,137
+29
| +0.7% | +$2.38K | 0.02% | 300 |
|
|
2024
Q1 | $358K | Sell |
4,108
-1,164
| -22% | -$99.3K | 0.02% | 297 |
|
|
2023
Q4 | $434K | Sell |
5,272
-2,355
| -31% | -$179K | 0.04% | 264 |
|
|
2023
Q3 | $598K | Sell |
7,627
-2,289
| -23% | -$192K | 0.06% | 188 |
|
|
2023
Q2 | $874K | Buy |
9,916
+764
| +8% | +$65.8K | 0.07% | 154 |
|
|
2023
Q1 | $738K | Buy |
9,152
+4,053
| +79% | +$330K | 0.06% | 176 |
|
|
2022
Q4 | $396K | Sell |
5,099
-5,326
| -51% | -$432K | 0.04% | 304 |
|
|
2022
Q3 | $842K | Sell |
10,425
-1,778
| -15% | -$160K | 0.08% | 139 |
|
|
2022
Q2 | $1.1M | Sell |
12,203
-1,145
| -9% | -$116K | 0.11% | 117 |
|
|
2022
Q1 | $1.38M | Hold |
13,348
| – | – | 0.11% | 102 |
|
|
2021
Q4 | $1.38M | Sell |
13,348
-523
| -4% | -$60.6K | 0.11% | 102 |
|
|
2021
Q3 | $1.74M | Buy |
13,871
+575
| +4% | +$74.4K | 0.16% | 78 |
|
|
2021
Q2 | $1.65M | Buy |
13,296
+5
| +0% | +$628 | 0.15% | 84 |
|
|
2021
Q1 | $1.57M | Buy |
13,291
+2,187
| +20% | +$256K | 0.15% | 79 |
|
|
2020
Q4 | $1.3M | Buy |
11,104
+1,131
| +11% | +$125K | 0.14% | 81 |
|
|
2020
Q3 | $1.04M | Buy |
9,973
+1,567
| +19% | +$157K | 0.13% | 82 |
|
|
2020
Q2 | $771K | Sell |
8,406
-479
| -5% | -$45.9K | 0.11% | 100 |
|
|
2020
Q1 | $801K | Buy |
8,885
+869
| +11% | +$92.4K | 0.15% | 80 |
|
|
2019
Q4 | $941K | Sell |
8,016
-581
| -7% | -$63.8K | 0.15% | 81 |
|
|
2019
Q3 | $934K | Buy |
8,597
+1,796
| +26% | +$187K | 0.17% | 76 |
|
|
2019
Q2 | $662K | Sell |
6,801
-1,086
| -14% | -$99.2K | 0.13% | 90 |
|
|
2019
Q1 | $718K | Buy |
7,887
+4,437
| +129% | +$397K | 0.17% | 76 |
|
|
2018
Q4 | $314K | Buy |
3,450
+882
| +34% | +$82.4K | 0.11% | 87 |
|
|
2018
Q3 | $253K | Sell |
2,568
-354
| -12% | -$32.7K | 0.09% | 101 |
|
|
2018
Q2 | $250K | Buy |
+2,922
| New | +$244K | 0.1% | 70 |
|
Other funds holding MDT
Clarius Group's MDT Position: Q4 2025 in Review
Clarius Group reduced its Medtronic (MDT) stake by 49% in Q4 2025, selling an estimated $284K and leaving 3,011 shares worth $289K. The position accounts for 0.02% of the portfolio, ranked #299.
Clarius Group first reported a position in MDT in Q2 2018 and has held it in 31 quarters since. The position peaked at $1.74M in Q3 2021. 2,325 funds tracked by Wall St. Rank hold MDT as of Q4 2025.
- Clarius Group held 3,011 shares of Medtronic worth $289K as of Q4 2025.
- Clarius Group sold 2,928 Medtronic shares in Q4 2025, an estimated $284K.
- Medtronic made up 0.02% of Clarius Group's portfolio in Q4 2025, its #299 holding.
- Clarius Group first reported a position in Medtronic in Q2 2018 and has held it in 31 quarters since.
- Clarius Group's Medtronic position peaked at $1.74M in Q3 2021.
- 2,325 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.
Based on Clarius Group's 13F filing for Q4 2025, filed 14 Jan 2026.